Skip to main content

Advertisement

Log in

Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background

Multiple predictive models of mortality exist for acute-on-chronic liver failure (ACLF) patients that often create confusion during decision-making. We studied the natural history and evaluated the performance of prognostic models in ACLF patients.

Methods

Prospectively collected data of ACLF patients from APASL-ACLF Research Consortium (AARC) was analyzed for 30-day outcomes. The models evaluated at days 0, 4, and 7 of presentation for 30-day mortality were: AARC (model and score), CLIF-C (ACLF score, and OF score), NACSELD-ACLF (model and binary), SOFA, APACHE-II, MELD, MELD-Lactate, and CTP. Evaluation parameters were discrimination (c-indices), calibration [accuracy, sensitivity, specificity, and positive/negative predictive values (PPV/NPV)], Akaike/Bayesian Information Criteria (AIC/BIC), Nagelkerke-R2, relative prediction errors, and odds ratios.

Results

Thirty-day survival of the cohort (n = 2864) was 64.9% and was lowest for final-AARC-grade-III (32.8%) ACLF. Performance parameters of all models were best at day 7 than at day 4 or day 0 (p < 0.05 for C-indices of all models except NACSELD-ACLF). On comparison, day-7 AARC model had the numerically highest c-index 0.872, best accuracy 84.0%, PPV 87.8%, R2 0.609 and lower prediction errors by 10–50%. Day-7 NACSELD-ACLF-binary was the simple model (minimum AIC/BIC 12/17) with the highest odds (8.859) and sensitivity (100%) but with a lower PPV (70%) for mortality. Patients with day-7 AARC score > 12 had the lowest 30-day survival (5.7%).

Conclusions

APASL-ACLF is often a progressive disease, and models assessed up to day 7 of presentation reliably predict 30-day mortality. Day-7 AARC model is a statistically robust tool for classifying risk of death and accurately predicting 30-day outcomes with relatively lower prediction errors. Day-7 AARC score > 12 may be used as a futility criterion in APASL-ACLF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ACLF:

Acute-on-chronic liver failure

MELD:

Model for end-stage liver disease

APASL:

Asian Pacific Association for the Study of the Liver

AARC:

APASL ACLF Research Consortium

INR:

International normalized ratio

LA:

Lactate

OFs:

Organ failures

CLIF-C:

Chronic Liver Failure Consortium

NACSELD:

North American Consortium for the Study of End-Stage Liver Disease

MELD-Na:

Model for end-stage liver disease-sodium

CTP:

Child–Turcotte–Pugh

SOFA:

Sequential organ failure assessment

APACHE-II:

Acute physiology and chronic health evaluation

C-index:

Concordance index

PPV:

Positive predictive value

AIC:

Akaike information criteria

BIC:

Bayesian information criteria

OR:

Odds ratio

SD:

Standard deviation

IQR:

Interquartile range

CANONIC:

Chronic liver failure acute-on-chronic liver failure in cirrhosis

References

  1. Jalan R, Perricone G, Moreau R, Arroyo V, Williams R. Acute-on-chronic liver failure: a new disease or an old one hiding in plain sight? Clin Liver Dis (Hoboken) 2020;15:S45–S51

    Google Scholar 

  2. Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int 2019;13:353–390

    Article  Google Scholar 

  3. Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int 2017;11:461–471

    Article  CAS  Google Scholar 

  4. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426–1437, 1437.e1421–1429

  5. Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-Fischer P, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015;62:831–840

    Article  Google Scholar 

  6. Drolz A, Horvatits T, Rutter K, Landahl F, Roedl K, Meersseman P, et al. Lactate improves prediction of short-term mortality in critically Ill patients with cirrhosis: a multinational study. Hepatology 2019;69:258–269

    Article  CAS  Google Scholar 

  7. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Gines P, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014;61:1038–1047

    Article  Google Scholar 

  8. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, et al. survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014;60:250–256

    Article  Google Scholar 

  9. O’Leary JG, Reddy KR, Garcia-Tsao G, Biggins SW, Wong F, Fallon MB, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology 2018;67:2367–2374

    Article  Google Scholar 

  10. Sarmast N, Ogola GO, Kouznetsova M, Leise M, Bahirwani R, Maiwall R, et al. Model for end-stage liver disease-lactate and prediction of inpatient mortality in patients with chronic liver disease. Hepatology 2020;72:1747–1757

    Article  Google Scholar 

  11. Kumar R, Krishnamoorthy TL, Tan HK, Lui HF, Chow WC. Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure. Gastroenterol Rep (Oxf) 2015;3:122–127

    Article  Google Scholar 

  12. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, et al. Proposal of a modified Child–Turcotte–Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12:65–71

    Article  Google Scholar 

  13. Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis 2013;14:484–490

    Article  CAS  Google Scholar 

  14. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver Int 2013;33:40–52

    Article  Google Scholar 

  15. Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis. Hepatology 2019;69:2150–2163

    Article  Google Scholar 

  16. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–96

    Article  Google Scholar 

  17. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012;56:2328–2335

    Article  CAS  Google Scholar 

  18. Karvellas CJ, Garcia-Lopez E, Fernandez J, Saliba F, Sy E, Jalan R, et al. Dynamic prognostication in critically Ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis. Crit Care Med 2018;46:1783–1791

    Article  Google Scholar 

  19. Rosenblatt R, Shen N, Tafesh Z, Cohen-Mekelburg S, Crawford CV, Kumar S, et al. The North American Consortium for the study of end-stage liver disease-acute-on-chronic liver failure score accurately predicts survival: an external validation using a national cohort. Liver Transpl 2020;26:187–195

    Article  Google Scholar 

  20. Cárdenas A, Solà E, Rodríguez E, Barreto R, Graupera I, Pavesi M, et al. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care 2014;18:700

    Article  Google Scholar 

  21. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157–172

    Article  Google Scholar 

  22. Kuha J. AIC and BIC: comparisons of assumptions and performance. Sociol Methods Res 2004;33:188–229

    Article  Google Scholar 

  23. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991;78:691–692

    Article  Google Scholar 

  24. Norton EC, Dowd BE. Log odds and the interpretation of logit models. Health Serv Res 2018;53:859–878

    Article  Google Scholar 

  25. Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology 2015;62:243–252

    Article  Google Scholar 

  26. Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology 2015;62:232–242

    Article  Google Scholar 

  27. Jeppesen JB, Mortensen C, Bendtsen F, Moller S. Lactate metabolism in chronic liver disease. Scand J Clin Lab Investig 2013;73:293–299

    Article  CAS  Google Scholar 

  28. Puskarich MA, Trzeciak S, Shapiro NI, Albers AB, Heffner AC, Kline JA. Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock. Chest 2013;143:1548–1553

    Article  CAS  Google Scholar 

  29. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361–387

    Article  Google Scholar 

  30. Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of ‘golden window’: a prospective study. J Gastroenterol Hepatol 2017;32:1989–1997

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was presented as an oral presentation at the 29th Asian Pacific Association for the Study of the Liver (APASL) 2020 in Bali, Indonesia.

Funding

None.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Radha Krishan Dhiman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants or legally acceptable representative of the participant included in the study.

Ethical approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki 1975, as revised in 2008. The AARC registry for ACLF was approved by the Institutional Ethical Review board at the nodal centre i.e. ILBS New Delhi (vide letter no F/25/5/64/AC2013/912) and all the participating centers also had necessary approval from respective ethical board.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 2680 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verma, N., Dhiman, R.K., Singh, V. et al. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF. Hepatol Int 15, 753–765 (2021). https://doi.org/10.1007/s12072-021-10175-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-021-10175-w

Keywords

Navigation